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Abstract
Pulmonary rehabilitation (PR) is an evidenced-based, proven treatment as mentioned 
recent guidelines in patients with chronic obstructive pulmonary disease (COPD). 
Exercise training is a cornerstone of PR programs, Inspiratory muscle training, neuro-
muscular electrical stimulation (NMES) are effective in selected patients. Water-based 
rehabilitation and tai chi are well tolerated recent modalities. Although there is an absence 
of a specific PR protocol for special conditions, PR is recommended before and also after 
endobronchial volume reduction (EBVR), lung volume reduction surgery (LVRS), both 
before and after lung transplantation periods, before, after surgery, during the inten-
sive care unit (ICU) period, the chemotherapy period and as a component of palliative 
care. After COPD exacerbation, it is recommended  within 3 weeks of hospital discharge. 
Modifying PR programs while considering comorbidities might lead to greater improve-
ment in outcomes. After PR, the important points are to follow prescribed home exercise 
programs, control programs in the PR center/unit, and being more active in daily living 
life for the purpose of preserving improvements. Tele-PR is an alternative to conven-
tional modalities due to similar improvements. Although PR is effective, it is an under-
utilized resource. The awareness of PR should be increased in patients and among health 
professionals.
Keywords: PR, exercise capacity, quality of life, perioperative lung transplantation, 
EBVR
1. Introduction
Chronic obstructive pulmonary disease (COPD), a systemic progressive disease that results 
in reduced exercise capacity and quality of life, progressive dyspnea, and mortality. It causes 
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health and economic burdens unless pharmacologic and nonpharmacologic treatments are 
optimized. One of the most important interventions is pulmonary rehabilitation (PR). It is a 
proven modality and is included in COPD treatment guidelines. The evidence-based benefits 
are improvement in exercise capacity and quality of life, recovery time after hospitalization, and 
survival; and reduction in perceived intensity of breathlessness, number of hospitalizations, 
and days in hospital; and enhancement of the effect of long-acting bronchodilators. Although 
most studies included patients with moderate-to-severe COPD and demonstrated evidence for 
these patients, PR is recommended for all patients who are symptomatic with reduced exercise 
capacity and quality of life, regardless of disease severity. PR is also an effective, feasible modal-
ity during the intensive care unit (ICU) period and early periods after exacerbation. The recom-
mended time for PR is during the perioperative period in lung transplantation. Additionally, 
PR is required before endobronchial volume reduction (EBVR) and has shown to be beneficial 
before and after lung cancer surgery. This chapter outlines the pathophysiologies that give rise 
to indications for PR, the latest developments in PR, and PR modalities associated with COPD.
2. The definition of PR
PR is described as “a comprehensive intervention based on a thorough patient assessment 
followed by patient-tailored therapies that include, but are not limited to, exercise training, 
education, and behavior changes, that is designed to improve the physical and psychological 
conditions of people with chronic respiratory disease, and to promote the long-term adher-
ence to health-enhancing behaviors [1].”
3. Pathophysiologies indicated for PR
3.1. Exercise limitation
Exercise intolarence is one of the most important and common symptoms experienced by 
patients with mild-to-severe COPD and are related to reduced health-related quality of life. 
Exercise intolerance in patients with COPD is primarily due to impaired ventilatory mechan-
ics, but it is also associated with gas exchange limitation, cardiovascular factors, peripheral 
skeletal muscle dysfunction and a combination of these [2, 3]. Additionally, anxiety and poor 
motivation are other factors of exercise intolerance. Although the exact association has yet to 
be found, it is thought that anxiety and depression contribute to exercise intolerance [4], due 
to the effect that these have on increased symptom perception [5, 6].
Ventilatory limitation: Multiple factors determine ventilatory limitation, which consists of 
abnormalities in ventilatory mechanics and ventilatory muscle function. Other reasons 
for ventilatory limitation are increased ventilatory demands as a result of changes in gas 
exchange, and discordance in the neuroregulatory control of breathing. The most impor-
tant pathophysiology in patients with COPD is expiratory flow limitation. During exercise, 
air becomes trapped, which results in dynamic lung hyperinflation (DH) above the already 
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increased resting volumes. Additionally, DH inhibits tidal volume expansion during exer-
cise and contributes to cardiac dysfunction by increasing the positive intrathoracic pressures, 
which likely contribute to cardiac impairment [7].
Gas exchange limitation: Hypoxia is likely to limit exercise tolerance. Hypoxia increases pul-
monary ventilation by enhancing output of peripheral chemoreceptors and production of lac-
tic acid. Lactic acidemia results in increased pulmonary ventilation because of an increase in 
carbon dioxide production due to buffered lactic acid [8]. Above the lactic threshold, severe 
dyspnea correlates with increased work rates. Dyspnea may quickly increase. Furthermore, 
plasma norepinephrine and epinephrine also increase during exercise [9, 10].
Cardiovascular factors: In patients with COPD, the cardiovascular system is influenced by vari-
ous mechanisms. The most important is an increase in right ventricular afterload through 
elevated pulmonary vascular resistance from direct vascular injury [11, 12], hypoxic vaso-
constriction [13], and/or increases in effective pulmonary vascular resistance due to eryth-
rocytosis [14]. In the course of time, the overloaded right ventricle leads to right ventricular 
hypertrophy, which could result in right ventricular failure [15]. During exercise, pulmonary 
vascular resistance is rapidly increased due to breathing at lung volumes close to total lung 
capacity [16, 17]. Lung hyperinflation and excessive expiratory muscle recruitment are likely 
to reduce venous return and right ventricular preload in COPD [18, 19]. Moreover, during 
exercise, large intrathoracic pressure swings for the purpose of overcoming the increased elas-
tic and resistive loads, may result in left ventricular dysfunction by increasing left ventricular 
afterload [20, 21]. These right ventricular effects can also compromise left ventricular filling 
through septal shifts that further reduce the ability of the heart to meet exercise demands [22].
Peripheral skeletal muscle dysfunction: Skeletal muscle dysfunction in patients with COPD is 
characterized by remarkably decreased muscle strength and endurance. The mechanisms are 
reduction in muscle mass and proportion of oxidative fibers, increases in the proportion of gly-
colytic fibers and muscle atrophy, and also a detoriation of oxidative metabolic capacity due 
to reductions in mitochondrial enzyme activities and capillary density. Additionally, systemic 
inflammation; malnutrition; corticosteroid use; hypoxemia; aging; smoking; the production 
of reactive oxygen and nitrogen species; enhanced protein degradation inside muscle fibers; 
increased activities of the proteasomal and lysosomal pathways; and activation of calpains 
and caspases contribute to muscle dysfunction. Therefore, patients with COPD enter into a 
vicious circle owing to disuse and inactivity due to the aforementioned mechanisms [23].
3.2. Body composition disorders
Unexplained weight loss occurs in about 50% of patients with severe COPD and 15% of patients 
with mild-to-moderate COPD [24, 25]. The main cause of weight loss in COPD is the reduc-
tion in skeletal muscle mass rather than loss of fat mass. Based on the reduction of fat mass or 
fat-free mass index (FFMI), nutritional abnormalities in COPD have been categorized into four 
types. Normal body mass index (BMI) with normal FFMI is normal, low BMI with normal or 
above-normal FFMI is defined as semistarvation, normal or above-normal BMI with low FFMI 
is defined as muscle atrophy, and low BMI with low FFMI as cachexia [26]. There are several 
reasons for weight loss in patients with COPD, even if during a stable period. In patients 
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with stable COPD, there is an increased metabolic rate due to abnormal respiratory dynam-
ics, chronic systemic inflammation, and drugs [27–31]. In malnourished mobile patients with 
COPD, although the basal metabolic rate is reduced, the resting energy expenditure is high. 
During exercise, inefficient muscle contractions due to increased consumption of adenosine 
triphosphate are added on. Also, there is an increase in the levels of inflammatory cytokines 
such as tumor necrosis factor-alpha (TNF-α) and interleukin (IL) 1 in circulation. TNF-α and 
IL1 have been shown to contribute to weight loss even in healthy individuals [32].
3.3. Psychological status
Patients with COPD have a higher prevalence of depression and anxiety than the general popula-
tion [33] and a higher risk for developing depression [34]. The etiology of the association between 
depression and COPD has not been revealed clearly. The most important risk factor for COPD 
is smoking. Depressed individuals are more likely to smoke [35], have a tendency to smoking 
[36, 37], and find smoking cessation more difficult [35, 38]. Conversely, smokers are more likely 
to be depressed [39], which could be caused by activation of nicotinic acetylcholine receptors 
[40], and the inflammatory effects of smoking [41]. Soluble tumor necrosis factor receptor-1 has 
shown to be associated with rates of depression in patients with COPD [42], but there is not exact 
relationship between TNF-α and COPD [43, 44]. Hypoxia is thought be an additional factor in the 
development of depression in COPD. Low arterial oxygen saturation has been shown to be asso-
ciated with periventricular white matter lesions [45], which are found in patients with depression 
[46]. Other important risk factors are the severity of symptoms and reported quality of life [47]. 
Depression is found more frequently in support-bound patients with COPD [48].
4. Content of PR programs
4.1. Exercise training
Exercise training is a cornerstone of PR programs. Exercise training is shown to be the best 
approach for increasing muscle strength, is likely to improve motivation for exercise, reduce 
mood abnormalities [49, 50], decrease symptoms [51], and improve cardiovascular function [1]. 
As recent major guidelines recommend, the main components of exercise training programs 
for patients with COPD are endurance and resistance training, which should be included in 
PR programs. Although none of the guidelines make clear, specific, and accurate recommenda-
tions for whole exercise training, they agree on endurance training at least 3 to 5 times weekly 
>60% of the maximal work rate. However, there is no consensus of initial workloads or in 
increasing the exercise load or program duration; the duration of exercise is recommended for 
at least 20 minutes and a target program duration of up to 12 weeks [52].
Inspiratory muscle training (IMT): Respiratory muscle training is a part of rehabilitation in 
selected patients with COPD. Respiratory strength has been found to correlate with improved 
pulmonary function, reduction of dyspnea severity, improved exercise tolerance, and enhanced 
functionality and quality of life [53, 54]. IMT is thought to contribute to contraction of the dia-
phragm by increasing type II fibers [55], which results in reduced inspiratory time [56] and 
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subsequently increased expiratory time. Hyperinflation is expected to eventually diminish 
[57]; therefore, IMT is thought to impact on dyspnea without any significant change in inspira-
tory pressure [58, 59].
Neuromuscular electrical stimulation (NMES): NMES is one of the recent rehabilitation modali-
ties that involve passive stimulation of contraction of the peripheral muscles through the 
application of an electric current via electrodes placed on the skin over the targeted muscles 
by depolarizing motor neurons. It aims to elicit beneficial training effects without causing 
dyspnea in patients who are unable to participate in PR programs. The stimulation-pulse 
duration is usually 250–400 μs, and stimulation frequency ranges from 8 to 120 Hz. Intensities 
range from 10 to 100 mA, and these are gradually increased throughout the entire stimula-
tion according to the patient’s individual tolerance. In a meta-analysis published in 2016, it 
was found that NMES improved quadriceps strength and exercise capacity; however, there 
was no statistically significant improvement in the degree of health-related quality of life 
in patients with moderate-to-severe COPD [60]. In several studies, it has been reported that 
NMES had an impact on the increase in type II fiber cross-sectional area with a decrease in 
type I fiber cross-sectional area of the muscle, and on the decrease in muscle oxidative stress 
in patients with COPD. Owing to the fact that NMES has a low impact on ventilation, heart 
rate, and dyspnea, it could be applied during periods of exacerbation, and during admission 
to the ICU for acute COPD exacerbation [61, 62].
Recent exercise training approaches: Besides conventional exercise trainings, there have been a 
few papers published recently about alternative exercise training modalities in patients with 
COPD. According to these studies, water-based rehabilitation [63] and tai chi were found as 
well tolerated and enjoyable [64, 65].
4.2. Other interventions
PR programs should be comprehensive and individualized according to patients’ needs. 
Other interventions are breathing strategies, bronchial hygiene techniques, psychological and 
nutritional recommendations and support if needed, and education of patients and care giv-
ers. Body composition abnormalities, especially malnutrition, have already been found to 
increase risks of mortality among patients with COPD. A significant improvement has been 
shown in pulmonary function in patients with COPD who have a higher fat, lower carbohy-
drate diet than the traditional high-carbohydrate diet [66]. Omega-3 polyunsaturated fatty 
acids (PUFA) have been shown to have an antiinflammatory effect and be effective in patients 
with COPD [67]. It is also important to relapse any deficiency of vitamin D due to the associa-
tion with early progression, myopathy/muscle weakness, and the immune-modulatory effect 
of vitamin D [27].
5. Outcomes and response to PR
It has been demonstrated that PR is the most effective therapeutic approach for improving 
dyspnea, health status, and exercise tolerance [68]. It is also one of the most cost effective 
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therapeutic strategies. Additionally, it reduces hospitalizations among patients who have had 
recent exacerbations [69]. Improvements are seen among all grades of COPD severity, but rec-
ommendations are stronger in moderate-to-severe COPD. In some studies, improvements of 
outcomes were seen regardless of baseline lung function, dyspnea, and exercise capacity [70].
5.1. Exercise capacity
Various exercise tests are used for evaluating exercise capacity, the mechanisms of main 
disruption, and the response to PR. Some are also strong independent prognostic factors in 
patients with COPD. There are several laboratory-based exercise tests that use either maximal 
incremental or constant workload protocols to evaluate exercise performance after PR. Field 
tests are more widely used and more practical to perform. The six-minute walk test (6MWT), 
incremental and endurance shuttle walk test (ISWT, ESWT) are standardized and have also 
been used in PR and various clinical trials. In COPD, endurance tests [constant work rate exer-
cise test (CWRET) and ESWT] are more responsive to interventions than other types of tests. 
The cycle ergometer CWRET has been used more widely than ESWT. By using CWRET, the 
work rate, inspiratory capacity, and isotime responses, which verify potential mechanisms of 
improvement or deterioration, are accurately measured [71].
The ISWT is a significant predictor of survival, readmission, and is usually sensitive to PR 
in patients with COPD [72]. In a recent meta-analysis of nine trials, a mean improvement of 
38 m was found [68]. After recovering from a stay in the ICU, ISWT was found to improve 
by a mean of 64 m after rehabilitation [72]. ESWT duration was found as moderately corre-
lated with FEV1, but not with muscle mass or strength in patients with COPD [73]. ESWT is 
responsive to PR improving by 100–400 s. [71]. According to a meta-analysis of rehabilitative 
interventions in COPD, the mean effect of rehabilitation on 6MWD was 44 m when treatment 
and control groups were compared [74].
Peak oxygen uptake (V′O2peak) shows the highest oxygen uptake during incremental exercise 
tests by achieving the subject’s limit of tolerance. With good subject effort, V′O2peak is closely 
reflective of the subject’s “maximum” V′O2, the gold standard index of aerobic capacity [75]. 
There is very little information about what constitutes a minimal clinically important differ-
ence (MCID) in V′O2peak. In the National Emphysema Treatment Trial (NETT), 4 ± 1 W was 
considered the symptoms-anchored MCID in patients with severe COPD [76], with a V′O2peak 
change of ∼0.04 ± 0.01 L·min−1. In several studies including patients with Global Initiative for 
Chronic Obstructive Lung Disease (GOLD) stages 2–4 COPD V′O2peak has been shown to 
moderately significantly increase after lower limb endurance muscle training. After PR in 
patients with COPD, V′O2peak was found to be in the range 0.1–0.5 L·min−1 or ∼10–40% of 
baseline, with a mean improvement of ∼11% [77, 78].
5.2. Health-related quality of life daily living activities
In a recent study, it was aimed to determine the responsiveness of St. George’s Respiratory 
Questionnaire (SGRQ), COPD Assessment Test (CAT), COPD Clinical Questionnaire (CCQ), 
and Hospital Anxiety and Depression Scale (HADS) to PR in 419 patients with COPD, and 
also estimate the MCID for CAT, CCQ, and HADS. It was demonstrated that SGRQ, CAT, 
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CCQ, and HADS were responsive to PR in patients with moderate-to-very-severe COPD. The 
calculated MCID ranges were −3.0 to −2.0 points for CAT; −0.5 to −0.3 points for CCQ; −1.8 to 
−1.3 points for HADS-A, and −1.7 to −1.5 points for HADS-D [79].
6. PR in special conditions
6.1. Before and after transplantation
Lung transplantation is a recommended intervention in patients with advanced-stage pul-
monary disease who are unresponsive to pharmacologic and nonpharmacologic treatment. 
Factors such as chronic respiratory failure, cardiovascular risk factors, muscular and nutri-
tional conditions, which are likely to influence the prognosis for a successful lung trans-
plantation, usually accompany advanced chronic respiratory disorders. Therefore, PR is an 
important approach that modifies and controls potential risk factors. PR plays an important 
role for the maintenance of exercise tolerance and physical functioning [80] both before and 
after the lung transplantation because common extra pulmonary manifestations could be per-
sistent or deteriorate. As such, PR is recommended both before and after lung transplanta-
tion. Although there is an absence of a specific PR protocol for patients for lung transplant, it 
was shown to improve maximal and functional exercise capacity, quality of life, and skeletal 
muscle function [81].
Before transplantation: The role of PR in preoperative patients is essential for quitting smoking, 
improving body composition, optimizing medical treatment, and restoring patients’ inde-
pendence for functioning, relieving symptoms, decreasing disability, and improving quality 
of life by increasing their participation in social and physical activities. It has been shown 
that the rate of success in lung transplantation was linked to exercise capacity and resting 
carbon dioxide in arterial blood values [82]. Those parameters were also found to predict 
hospital stay after surgery and mortality. Additionally, pretransplant PR was also found to 
be associated with decreased posttransplant ICU days, mechanical ventilation, and chest tube 
days and survey [83]. Multidisciplinary, comprehensive PR must be individualized and the 
modality and intensity of training must be selected for each patient. The duration of training 
can vary from 6 weeks to 6 months [84]. The program should consist of education (including 
the following topics: bronchial hygiene, breathing control techniques, relaxation, education 
about COPD, and education of relatives and energy conservation), exercise training (upper 
and lower limb aerobic exercise, resistance training, flexibility, inspiratory muscle training), 
psychological support, and nutritional support. The intensity of exercise is dynamically 
increased according to the progress of each individual patient.
After transplantation: Although pulmonary functions are improved after transplantation, limited 
exercise capacity is persistent due to different mechanisms. Persistent limited exercise capacity is 
not only associated with ventilatory or cardiovascular factors [85, 86], skeletal muscle dysfunction 
is the main problem. Skeletal muscle changes include impaired oxidative capacity, lactate thresh-
old changes, and a lower proportion of type I muscle fibers [87]. A sedentary life style both before 
and after transplantation contributes to skeletal muscle weakness [88]. Hospitalizations due to 
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infections or acute rejections and the use of immunosuppressive medication further impact mus-
cle function in lung recipients [89]. It was found that V′O2 peak was 45–52% predicted in patients 
after lung transplantation for up to 2 years. Patients stop exercise because of leg fatigue, rather 
than dyspnea [90]. Additionally, maximal cycle-work capacity correlates better with isokinetic 
cycling work capacity than with pulmonary function after lung transplantation [91]. PR should 
be started in the ICU with positioning of the patient, ventilation of all lung lobes, and mobilization 
of secretions by managing cough. Deep breathing exercises should be initiated because tachy-
pnoea and pursed-lip breathing persist postoperatively and old breathing patterns must be over-
come. Sitting and mobilization out of bed should then be performed. After all chest drains have 
been removed, walking or cycle ergometry should performed. Muscle strength and function, and 
endurance training should focus on lower extremities, and weights can be limited to 3 kg initially 
for upper extremities [92]. After discharge, patients should be referred to PR center/units as soon 
as possible. Although there is no consensus on optimal exercise training and education programs, 
aerobic and strength exercise training of the lower and upper extremities 2–3 times per week for 
6–8 weeks, are recommended. The intensity of exercise can be increased according to patient 
tolerance. High-intensity aerobic exercise training at 60–80% of maximal work capacity has been 
found to be correlated with physiologic improvements in patients with stable COPD. Hence, 
high-intensity training is preferred. Interval training could be applied in patients who cannot sus-
tain continuous high-intensity. Stretching, flexibility, and chest-mobility exercises may also be an 
important component of exercise after LVRS or transplantation [1, 82, 93]. Education of patients 
and care givers is also an important issue.
6.2. Lung volume resection surgery (LVRS)
Similar recommendations are valid for LVRS, which is not usually an effective intervention for 
exercise intolerance and functional disability. Baseline skeletal muscle dysfunction, time needed to 
achieve postoperative improvement in lung function (peak benefits are usually seen 6–12 months 
after surgery), and inactivity/immobility associated with the perioperative period are factors that 
reduce exercise capacity. Several studies compared the benefits of LVRS and several-weeks’–
duration comprehensive PR in patients with severe emphysema. PR was found to significantly 
improve exercise tolerance, health status, and dyspnea, without significant changes in lung func-
tion as compared with PR and LVRS, even if highly selected patients showed significantly better 
improvement in lung function [94–97], exercise capacity [95–97], and quality of life [96, 97].
6.3. Endobronchial volume reduction (EBVR)
Endobronchial volume reduction interventions result in improved spirometric measures and 
6MWD at 6 months, only if in correctly selected subjects. PR is recommended before and 
after EBVR, which is indicated in the presence of persistent dyspnea despite maximal medi-
cal therapy and PR, and reduced exercise capacity (6MWD ≥140 m after rehabilitation) [97].
6.4. Lung cancer
In patients with lung cancer, exercise limitations can be due to the effects of the cancer, coex-
isting morbidities, and/or the effects of treatment and surgery. Cancer-related anemia, and 
muscle atrophy and dysfunction contribute to limited exercise capacity. Inactivity due to 
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cancer and its comorbidities further compound this situation. In the pre- and postoperative 
period, quitting smoking, optimizing COPD medical treatment, educating patients, prophy-
laxis for thrombosis, and PR are the recommended approaches that decrease risks. PR is an 
effective and feasible intervention before and after surgery, during the chemotherapy period, 
and as a component of palliative care. Even though PR consists of an exercise program for 
lower and upper extremities, breathing, airway clearance techniques, oxygen therapy, bron-
chodilator optimization, and self-management training similar to other conditions, it should 
also be individualized and multidisciplinary in patients with cancer.
Even though surgical procedures have improved and patients are highly selected, morbidity 
and mortality rates are still increasing as a consequence of cardiopulmonary complications after 
surgery. Limited exercise capacity as a modifiable risk factor is the best independent predictor 
of postoperative complications. Multidisciplinary preoperative PR improves exercise capacity 
and postoperative recovery, and reduces hospital stay and pulmonary infections [98]. During 
the chemotherapy period, symptoms such as fatigue, breathlessness, and quality of life are 
likely to deteriorate. Exercise training improves fatigue, aerobic capacity, muscular strength, 
and physical and functional activity in patients with cancer, even though they are undergoing 
chemotherapy [99]. Breathing techniques and medications that result in reduced inflammation 
and opened airways in combination with exercise training have recently become a part of sup-
portive care for patients undergoing chemotherapy and radiation therapy [100]. PR plays a role 
in the management of terminal cancer. Exercise training modalities include walking with/with-
out assistance or device, passive or active strengthening exercises, continuous passive motion, 
passive or active range of motion, NMES, and pain management interventions such as massage 
and heating pads [101]. Oxygen therapy has an important role in palliative care because it both 
treats hypoxemia and reduces the sensation of dyspnea. Additionally, education about mobi-
lization with assistive devices, environmental modification, energy conservation, and work 
simplification techniques are also beneficial. These interventions have been investigated and 
were shown to be effective in cancer-related fatigue in several studies [102–104]. In another 
study, it was shown that exercise training decreased anxiety, stress, depression, and there were 
improvements in pain, fatigue, shortness of breath, constipation, and insomnia in patients with 
cancer, even at advanced stages [105].
6.5. Exacerbation of COPD
COPD exacerbations are known to deteriorate life quality, disease progression, and mortality. 
The British Thoracic Society (BTS) recommends the initiation of PR within 1 month of hospital 
discharge after exacerbation, consisting of a minimum of twice-weekly supervised sessions 
lasting between 6 and 12 weeks [106]. Exercise should combine progressive muscle resistance 
and aerobic training [106]. Systematic reviews have shown that quality of life and daily func-
tioning were improved with large and important clinical effects of PR [107, 108]. According 
to the European Respiratory Society (ERS)/American Thoracic Society (ATS) guidelines of 
management of COPD exacerbations, PR added to medical treatment during hospitaliza-
tion increases mortality [109]; however, NMES and resisted quadriceps exercises performed 
during hospitalization during exacerbation have been shown to improve muscle strength 
without increasing systemic inflammation. PR that is started within 3 weeks of discharge fol-
lowing a COPD exacerbation reduces hospital admissions, improves quality of life, and also 
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increases exercise capacity when implemented within 8 weeks of discharge. Although the 
best approach is indistinct and further investigations are necessary, a combination of regular 
exercise with breathing technique training has been shown to be superior [109].
6.6. PR in the intensive unit care
In the ICU, skeletal muscle mass is lost at a rate of 5% per week. This neuromuscular weakness 
has been found to be correlated with the duration of mechanical ventilation, and associated 
with functional disability and decreased quality of life for up to 5 years after hospitalization. 
Mobilization and rehabilitation of critically ill patients might improve physical functioning 
and decrease duration of mechanical ventilation and ICU length of stay [110, 111]. A meta-
analysis was published in 2017 that consisted of studies with PR programs containing patient 
mobilization, walking, standing, breathing exercises, in-bed supine cycle ergometry, passive-
active range of motion (ROM), and NMES. It was shown that early mobilization and physical 
rehabilitation of critically ill patients seemed to be safe, with a low risk of potential safety 
events, even if as a usual care. Although the definition of safety assessments was heteroge-
neous, it was emphasized that the awareness and implementation of existing recommenda-
tions should be increased [112].
6.7. Patients with hypercapnia
Hypercapnia is an indicator of alveolar hypoventilation due to an overload on the ventila-
tory pump that is greater than its capacity. In patients with COPD, diminished ventilatory 
response usually results in chronic retention of carbon dioxide. Chronic respiratory failure 
is frequently seen in the end stage of the progression of COPD. In the BTS guidelines, it is 
mentioned that patients with chronic respiratory failure gain as much benefit as those without 
chronic respiratory failure from PR with level 3 evidence [106]. A study showed that pCO2 
levels were significantly more reduced in patients with COPD with pursed-lip and diaphrag-
matic breathing exercises during hospitalization period than in a control group. It was sug-
gested that respiratory exercise training was quite effective in reducing pCO2 levels. As the 
guidelines recommend, patients with COPD should be referred for PR regardless of having 
chronic respiratory failure [113].
Noninvasive mechanical ventilation (NIMV): Noninvasive mechanical ventilation (NIMV) 
reduces breathlessness and increases exercise tolerance by reducing the acute load on the 
respiratory muscles. According to these mechanisms, the effect of NIMV on PR outcomes has 
been investigated in several studies in which NIMV was applied during exercise training or 
at night. In a review of the Cochrane Database in which the effect of NIMV was investigated 
during exercise training as a part of PR, it was shown that NIMV during exercise training 
improved exercise capacity of the lower limbs, and enabled exercise at higher training intensi-
ties. There was no definite evidence about quality of life and none of the studies investigated 
the effect of NIMV during exercise training on physical activity [114]. It has also been shown 
that exercise tolerance and quality of life were improved in patients with severe COPD using 
nocturnal NIMV after PR, presumably through resting the respiratory muscles at night [115]. 
As a recommendation of the ERS/ATS guidelines, NIMV could be an adjunctive therapy to 
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unload the respiratory muscles for the purpose of increasing the intensity of exercise training 
in selected patients with severe chronic respiratory disease who have a suboptimal response 
to exercise [1].
6.8. Comorbidities
The most common comorbidities associated with COPD are cardiovascular disease, ortho-
pedic problems, metabolic disease, depression, and anxiety. It is expected that comorbidities 
may effect the outcomes of PR as an impact on COPD outcomes such as quality of life, health 
care costs, and mortality rate. Various comorbidities such as anxiety and depression, cardio-
vascular disease, metabolic disease, and osteoporosis affected PR outcomes in some studies 
[116–121]; a meta-analysis could not be performed according to the heterogeneous results. 
Only four studies investigated the influence of the number of comorbidities on PR outcomes. 
Three of which showed that the number of comorbidities was not related to PR outcomes 
[117, 119, 120]. A study showed that metabolic disease negatively influenced 6MWT distance, 
whereas cardiac disease negatively influenced the St. George’s Respiratory Questionnaire 
[118]. A prior study of patients with COPD with osteoarthritis and neurologic problems who 
were assigned to water-based exercise training reported a greater improvement in outcomes 
compared with land-based exercise training [121]. Previous studies have identified that 
patients with psychiatric problems experienced a lesser improvement in dyspnea [117], and 
patients with metabolic disease demonstrated a greater improvement in dyspnea after PR 
compared with controls [118]. A study was published in 2017 that included 165 patients with 
COPD with exercise limitations. Comorbidity was classified as cardiac, metabolic, orthopedic, 
behavioral health problems, or other diseases. Comorbidities were found to have no effect 
on the maximal incremental exercise test and constant workload cycle endurance time after 
PR. Patients with cardiac disease were found to have greater improvements in dyspnea scores 
than those with no cardiac disease, and patients with orthopedic problems had a smaller but 
clinically significant improvement in dyspnea after PR [122]. Modifying PR programs with 
consideration to comorbidities might lead to greater improvement in outcomes, but how to 
structure programs according to comorbidities is still to be determined.
7. Follow-up programs of PR and Tele-PR
The best and the most effective follow-up program have not been found. After PR, the impor-
tant points are to follow prescribed home exercise programs and follow-up programs in the 
PR center/unit, and to be more active in daily living life for the purpose of preserving improve-
ments. Accordingly, family members have a role that is as important as that of the PR center 
staff in encouraging and motivating the patients. In a cohort of patients with COPD who 
completed a 10-week comprehensive PR program, a structured follow-up home program was 
prescribed and the patients were monitored for 1 year. At the 1-year follow-up evaluation, 
only the patients who continued with the home program had maintained the improvements 
of the initial PR program in endurance capacity, and psychological and cognitive functioning 
[123, 124]. Despite the clear benefits of PR, it is often an under-utilized resource. Limited 
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access and poor adherence result in <5% of eligible people with COPD receiving PR each 
year. Although the traditional models of inpatient and outpatient PR are suitable for many 
patients, alternative models may also be effective and may improve patient access, particu-
larly in regions or healthcare systems where traditional models of PR are not feasible. For 
example, tele-rehabilitation, which links expert rehabilitation healthcare providers with oth-
ers at a remote site or with patients in their homes, also has the potential to improve access 
[125]. A recent study showed that home-based maintenance tele-rehabilitation was equally as 
effective as hospital-based, outpatient, maintenance PR in reducing the risk for acute exacer-
bations of COPD and hospitalizations with lower risk for emergency department visits. It was 
suggested that tele-rehabilitation was likely to be an effective alternative strategy to hospital-
based, outpatient, maintenance PR. In addition, it had a potential economic advantage com-
pared with standard PR [126]. Tele-PR has been developed to improve patients’ participation 
and treatment adherence, but the most important point is awareness. The awareness of PR 
should be increased in patients and among health professionals.
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